Related references
Note: Only part of the references are listed.MiR-195-3p inhibits cell proliferation in cervical cancer by targeting BCDIN3D
Minfei Jin et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2021)
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. Bossi et al.
ANNALS OF ONCOLOGY (2021)
Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis
Jinqin Chen et al.
ONCOLOGY LETTERS (2021)
microRNAs - Game-changers in plant symbioses
Patrick Schafer
JOURNAL OF PLANT PHYSIOLOGY (2021)
MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells
Hong Liu et al.
PLOS ONE (2021)
CDK1 in Breast Cancer: Implications for Theranostic Potential
Sepideh Izadi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2020)
CDK1 couples proliferation with protein synthesis
Katharina Haneke et al.
JOURNAL OF CELL BIOLOGY (2020)
UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
Hao Yang et al.
CANCER CELL INTERNATIONAL (2020)
miR-96-5p Suppresses the Progression of Nasopharyngeal Carcinoma by Targeting CDK1
Xiaoqin Luo et al.
ONCOTARGETS AND THERAPY (2020)
Chemotherapy and chemo-resistance in nasopharyngeal carcinoma
Shuzhen Guan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Cyclin B1/CDK1-regulated mitochondrial bioenergetics in cell cycle progression and tumor resistance
Bowen Xie et al.
CANCER LETTERS (2019)
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner
Jia-Yi Qian et al.
ONCOGENE (2019)
Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
Jiawei Lv et al.
NATURE COMMUNICATIONS (2019)
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Kioomars Saliminejad et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
miR-483-5p decreases the radiosensitivity of nasopharyngeal carcinoma cells by targeting DAPK1
Yunhong Tian et al.
LABORATORY INVESTIGATION (2019)
Targeting CDK1 and MEK/ERK Overcomes Apoptotic Resistance in BRAF-Mutant Human Colorectal Cancer
Peng Zhang et al.
MOLECULAR CANCER RESEARCH (2018)
Tetrandrine enhances radiosensitivity through the CDC25C/CDK1/cyclin B1 pathway in nasopharyngeal carcinoma cells
Jun Wang et al.
CELL CYCLE (2018)
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial
Lin-Quan Tang et al.
LANCET ONCOLOGY (2018)
Chemokine CCL4 Induces Vascular Endothelial Growth Factor C Expression and Lymphangiogenesis by miR-195-3p in Oral Squamous Cell Carcinoma
Ming-Yu Lien et al.
FRONTIERS IN IMMUNOLOGY (2018)
miR-206 enhances nasopharyngeal carcinoma radiosensitivity by targeting IGF1
Tian Wang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2017)
Identification of miR-195-3p as an oncogene in RCC
Lu Jin et al.
MOLECULAR MEDICINE REPORTS (2017)
miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma
Shaojun Chen et al.
ONCOTARGET (2017)
Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5
S. Wang et al.
ONCOGENE (2016)
MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1
Min Kang et al.
CANCER MEDICINE (2016)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Progressive Activation of CyclinB1-Cdk1 Coordinates Entry to Mitosis
Olivier Gavet et al.
DEVELOPMENTAL CELL (2010)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Share Paper
